PharmAsia News’ India Pharma Roundup: Biological E., Suven Life Sciences, Strides Arcolab, Dabur, Glenmark

MUMBAI - Biological E., which has a clinical trial network of 13,000 doctors and hospitals across India, signed an option and license agreement with U.S.-based Heparinex and Choncept to work on development of new methods to make anti-coagulant chondroitin derived from fermentation of recombinant bacteria to replace chondroitin sourced from beef and other animal by-products